glutamine has been researched along with Adenocarcinoma, Clear Cell in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Baker, R; Bazzaro, M; Clemente, V; Erickson, BK; Hoshino, A; Khalifa, M; Lou, E; Nelson, A; Rubin, N; Shetty, M; Weroha, SJ | 1 |
Adachi, K; Arimoto, T; Eguchi, S; Fujii, T; Fujikawa, T; Fujimoto, A; Inoue, T; Kawana, K; Nagamatsu, T; Nakamura, H; Nishida, H; Oda, K; Ogishima, J; Osuga, Y; Sato, M; Taguchi, A; Tomio, K; Wada-Hiraike, O; Yamashita, A; Yoshida, M | 1 |
Adachi, K; Eguchi, S; Fujii, T; Fujimoto, A; Inoue, T; Kawana, K; Nagamatsu, T; Nakamura, H; Nishida, H; Oda, K; Ogishima, J; Osuga, Y; Sato, M; Taguchi, A; Tomio, K; Wada-Hiraike, O; Yamashita, A; Yoshida, M | 1 |
3 other study(ies) available for glutamine and Adenocarcinoma, Clear Cell
Article | Year |
---|---|
GLS1 is a protective factor in patients with ovarian clear cell carcinoma and its expression does not correlate with ARID1A-mutated tumors.
Topics: Adenocarcinoma, Clear Cell; Animals; DNA-Binding Proteins; Female; Glutaminase; Glutamine; Humans; Mice; Ovarian Neoplasms; Protective Factors; Transcription Factors | 2022 |
Low uptake of fluorodeoxyglucose in positron emission tomography/computed tomography in ovarian clear cell carcinoma may reflect glutaminolysis of its cancer stem cell-like properties.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Blotting, Western; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glutamine; Humans; Middle Aged; Neoplasm Staging; Neoplastic Stem Cells; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Signal Transduction; Tumor Cells, Cultured; Young Adult | 2017 |
Targeting glutamine metabolism and the focal adhesion kinase additively inhibits the mammalian target of the rapamycin pathway in spheroid cancer stem-like properties of ovarian clear cell carcinoma in vitro.
Topics: Adenocarcinoma, Clear Cell; Aminooxyacetic Acid; Cell Culture Techniques; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Therapy, Combination; Enzyme Inhibitors; Female; Focal Adhesion Kinase 1; Glutamine; Humans; Ovarian Neoplasms; Phosphorylation; Quinolones; RNA, Messenger; Sequence Analysis, RNA; Signal Transduction; Spheroids, Cellular; Sulfones; TOR Serine-Threonine Kinases; Transaminases | 2017 |